New Roche Drug Appears to Improve Upon Tecentriq in Lung Cancer

(Bloomberg) -- Adding an experimental new treatment from Roche Holding AG to the company’s lung cancer drug, Tecentriq, appeared to drive more responses than Tecentriq by itself, according to resul...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.